ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.405,35
0,52%
S&P 500
5.969,34
0,35%
Dow Jones
44.296,51
0,97%
Euro vs US Dollar
1,04912
0,70%
Bitcoin
98.414,05
0,38%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Horizon Therapeutics Public Limited Company (HZNP)

  7. Horizon Therapeutics Public Limited Company (HZNP) News

HZNP

Horizon Therapeutics Pub... (HZNP)

Horizon Therapeutics Public Limited Company
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:HZNP
DatumZeitQuelleÜberschriftSymbolFirma
16/10/202322h44Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:HZNPHorizon Therapeutics Public Limited Company
09/10/202313h33IH Market NewsMonday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers, Disney, Lockheed Martin, and moreNASDAQ:HZNPHorizon Therapeutics Public Limited Company
07/10/202300h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
07/10/202300h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
07/10/202300h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
07/10/202300h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
07/10/202300h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202323h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202323h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202323h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h30Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h26Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h24Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h18Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h16Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h11Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h08Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202314h30Business WireRule 17(e) Announcement - Horizon Therapeutics plcNASDAQ:HZNPHorizon Therapeutics Public Limited Company
05/10/202313h40Business WireRule 17(d) Announcement – Horizon Therapeutics plcNASDAQ:HZNPHorizon Therapeutics Public Limited Company
05/10/202313h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HZNPHorizon Therapeutics Public Limited Company
03/10/202317h15Business WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
03/10/202317h06Business WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
02/10/202317h39Business WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
02/10/202317h24Business WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
02/10/202314h00Business WireHorizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023NASDAQ:HZNPHorizon Therapeutics Public Limited Company
 Showing the most relevant articles for your search:NASDAQ:HZNP

Kürzlich von Ihnen besucht

NYSE
MCD
McDonalds
TG
RHM
Rheinmetall
USOTC
DTEGY
Deutsche Telekom (QX)
DBI
MDAX
MDAX
PM
XAUUSD
Gold vs US Dollar
COIN
AVAXUSD
Avalanche
NASDAQ
AMZN
Amazon.com
DBI
TDXP
Tec DAX
NYSE
XOM
Exxon Mobil
TG
MBG
MercedesBenz
AMEX
XLV
Health Care Select Sector
NASDAQ
MSFT
Microsoft
AMEX
XLF
Financial Select Sector
COIN
DOGEUSD
Dogecoin
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten